Pharmaceutical Preparations · DE · CIK 1743881
Discovers, develops, and delivers medicines for patients with genetic diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 13, 2026: 6 sold $30.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 13, 2026 | Kumar NeilChief Executive Officer | Sell | 10,310 | $69.20 | $713K |
| Mar 13, 2026 | Kumar NeilChief Executive Officer | Sell | 10,241 | $68.39 | $700K |
| Mar 13, 2026 | Kumar NeilChief Executive Officer | Sell | 9,759 | $69.23 | $676K |
| Mar 13, 2026 | Kumar NeilChief Executive Officer | Sell | 9,690 | $68.36 | $662K |
| Mar 12, 2026 | Kumar NeilChief Executive Officer | Sell | 14,337 | $68.48 | $982K |
| Mar 12, 2026 | Kumar NeilChief Executive Officer | Sell | 13,885 | $68.47 | $951K |
| Mar 12, 2026 | Kumar NeilChief Executive Officer | Sell | 5,815 | $69.29 | $403K |
| Mar 12, 2026 | Kumar NeilChief Executive Officer | Sell | 5,363 | $69.32 | $372K |
| Mar 12, 2026 | Kumar NeilChief Executive Officer | Sell | 300 | $70.15 | $21K |
| Mar 10, 2026 | Valantine HannahDirector | Sell | 8,671 | $72.00 | $624K |
| Mar 4, 2026 | Ellis AndreaDirector | Sell | 64,921 | $64.87 | $4.2M |
| Feb 27, 2026 | Valantine HannahDirector | Sell | 14,584 | $67.08 | $978K |
| Feb 27, 2026 | Valantine HannahDirector | Sell | 10,900 | $67.84 | $739K |
| Feb 26, 2026 | Apuli MaricelChief Accounting Officer | Sell | 2,000 | $66.00 | $132K |
| Feb 19, 2026 | Kumar NeilChief Executive Officer | Sell | 18,923 | $71.03 | $1.3M |
| Feb 19, 2026 | Kumar NeilChief Executive Officer | Sell | 8,528 | $72.08 | $615K |
| Feb 19, 2026 | Kumar NeilChief Executive Officer | Sell | 602 | $72.80 | $44K |
| Feb 17, 2026 | Trimarchi ThomasPresident and CFO | Sell | 13,400 | $74.71 | $1.0M |
| Feb 17, 2026 | Scott Randal W.Director | Sell | 4,793 | $75.57 | $362K |
| Feb 17, 2026 | Scott Randal W.Director | Sell | 3,307 | $75.93 | $251K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.